1/2009- Directeur de Recherche Classe Exceptionnelle Inserm
1/2008- Chairman, Centre de Psychiatrie & Neuroscience, UMR 894 Inserm UPD
9/2006- Associate professor Inserm/Université Paris Descartes
1/2006- Comité d’orientation stratégique de l’Université Paris Descartes Member
1/2006- PhD programme GC2ID Université Paris Descartes committee Member
2001-2009 Chairman Institut Fédératif de Recherches Broca-Sainte-Anne
2001-2008 Directeur de Recherche Inserm (1ere classe = 1st class professor)
2000-2007 Director UMR 549 Inserm Université Paris Descartes
1987-2000 Directeur de Recherche Inserm (2eme classe= 2nd class full professor)
1982-1986 Chargé de recherche Inserm (= associate researcher)
1979-1981 Attaché de recherche Inserm (= asssitant researcher)
1978-1979 FRM fellow, Inserm U 159 (Dr. C Kordon)
1975-1977 Killam fellow, McGill Univ. & Montreal Neurological Institute (Prof. JB Martin),
1973-1974 PhD student U 109 Inserm (Prof JC Schwartz/ Dr. C Kordon)
@font-face { font-family: "Arial"; }@font-face { font-family: "Times"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; }
Jacques Epelbaum is chairman of the «Centre Psychiatrie et Neurosciences Inserm, UMR 894 Inserm Faculté de Médecine Université Paris Descartes à l’Hôpital Sainte-Anne à Paris ». He is also director of a research team in the Center : Neuroendocrinology of Growth & Aging. This team presently develop two scientific projects: 1) the characterisation of neuroendocrine networks which control body growth and metabolism under normal and pathological (growth retardation and eating disorders) conditions 2) the rôle of growth-involved neuromodulators (somatostatin, IGF-1) in cognitive aging.
In the past, he characterised somatostatin deficits in neurodegenerative diseases such as Alzheimer’s and Parkinson’s dementia.
Co-author of 251 articles indexed in Medline, over 100 reviews or book chapters, more than 400 abstracts, and 5 books, he is presently chairing the «Publication and communication committee of the Federation of European Neuroscience Societies (FENS) », he is also a member of the Executive Committees of FENS and the International Federation for Neuroendocrinology», He has been a member of the Advisory Panel of the NIH/NIA Aging Systems and Geriatrics Study Section , was a member of the « conseil scientifique de l’association France-Alzheimer from 1986 to 2010 and has recently been elected as représentative of the scientists in the « conseil d’administration de la Fondation Plan Alzheimer ».